Three enzyme immunoassays were used for the serodiagnosis of Trypan8osoma evansi in camels in the Sudan in order to evaluate their ability to discriminate between infected and non-infected animals. Two assays were used for the detection of trypanosomal antibodies, one using specific anti-camel IgG conjugate and another using a non-specific Protein A conjugate. The third assay detected the presence of trypanosomal antigens using anti-T. evansi antibodies in a double antibody sandwich assay. Inspection of the frequency distribution of assay results suggested that the ELISA for circulating trypanosomal antibodies using specific antisera and the ELISA for circulating antigens can distinguish between noninfected camels and infected camels exhibiting patent infections or not. The ELISA using Protein A conjugate to bind non-specifically to camel immunoglobulin did not appear to discriminate between infected and non-infected animals.
INTRODUCTION
Infections of livestock with Trypanosoma evansi occur in many countries in Asia, northern Africa and Latin America. Trypanosomiasis in the camel (Camelus dromedarius) has been recognized as an important disease of livestock in the Sudan since the beginning of this century. According to a recent animal census (Boid, Jones & Luckins, 1986) , the camel population in Sudan was approximately [2] [3] [4] [5] million, the majority of animals being in the eastern and western regions. Dromedary camels are important to the nomadic peoples of Northern Sudan because, in addition to providing food, transport and clothing, they also represent personal wealth within the community. The province of Kassala supports a large population of camels, and veterinarians there still rank trypanosomiasis as a major threat to the camel industry.
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Control of the disease by drug treatment relies on effective diagnosis primarily on parasitological techniques (Godfrey & Killick-Kendrick, 1962) . In order to improve diagnostic efficiency, several serological tests have been used to detect T. evansi antibodies in the camel. These include the complement fixation test (Schoening, 1924) , indirect fluorescent antibody assays (Luckins et al. 1979 ) and indirect haemagglutination tests (Wilson et al. 1983) .
More recently, the enzyme-linked immunosorbent assay (ELISA) has been developed for the detection of Trypanosoma spp. antibodies and antigens in animal sera (Luckins & Mehlitz, 1978; Luckins et al. 1979; Rae & Luckins, 1984) .
The ELISA is a test that is both analytically and diagnostically sensitive and diagnostically specific. Interpretation of results can be quantitative and objective, and the assay may be fully automated, so that large numbers of sera can be screened (Ruitenberg et al. 1977) .
The purpose of the present study was to evaluate the ability of three enzyme immunoassays to discriminate between infected and non-infected camels, using blood samples collected from camels in the Sudan over a 2-year period.
MATERIALS AND METHODS
Serum samples A total of 944 serum samples was collected from camels (Camelus dromedarius) in Kassala Province, Eastern Sudan, during the period January 1985 to December 1986. Eighteen serum samples were collected from police camels submitted for their annual veterinary inspection during June and July 1985; 29 samples were obtained from camels at a slaughterhouse in June 1985; the remaining 897 samples were collected from sick camels, possibly with trypanosomiasis, presented by their owners at Kassala Veterinary Clinic. All sera were heat inactivated at 56°C for 30 min before shipment to the Centre for Tropical Veterinary Medicine for ELISA testing. 'Negative' control sera were collected from four camels kept at Edinburgh Zoological Park, Scotland. These were also heat inactivated as described.
Parasitological diagnosis
Venous blood samples were taken from the jugular vein and collected into ethylenediaminetetra-acetic acid (EDTA) for parasitological examination. The microhaematocrit centrifuge technique (Woo, 1970) Ten mice were infected with T. evansi and, after a fulminating parasitaemia had developed, blood was collected. Blood was passed through a column of diethylaminoethyl cellulose (Whatman, DE52) as described by Lanham & Godfrey (1970) , in order to separate parasites from blood elements. The trypanosome suspension was centrifuged at 3200 g for 15 min, the supernate discarded, and the resulting pellet washed three times in 100 mm phosphatebuffered saline, pH 7-2 (PBS) by centrifugation at 2500 g for 15 min. The trypanosomes were resuspended to 1-0 ml in PBS and the antigens prepared using the method described by Luckins (1977) . The protein content of each antigen preparation was determined using BCA protein assay reagent (Pierce Chemical Company). Antigens were subsequently stored at -79°C until required.
Reagents for use in ELISA Horseradish peroxidase-conjugated rabbit anti-camel IgO Rabbit anti-camel IgG antiserum was prepared as described elsewhere (Boid et al. 1980) . Horseradish peroxidase (Type VI, Sigma) was conjugated to the specific antiserum using the technique described by Wilson & Nakane (1978) . Conjugates in PBS containing 0-15 mm bovine serum albumin were sterilized by filtration through a 0-22 ,um filter (Millipore) and stored at -20°C until used.
Horseradish peroxidase-labelled staphylococcal Protein A Conjugated protein A was obtained commercially (Sigma) in a lyophilized form.
After reconstitution according to the manufacturer's instructions, the conjugate was divided into 50 ,1 amounts and stored at -20 'C.
Production of anti-T. evansi antiserum and conjugate Adult male New Zealand White rabbits were used for the production of serum against a sonicated T. evansi (TREU 1942) antigen preparation. The method described by Thalhamer & Freund (1984) was applied. Briefly, 2 mg soluble trypanosome protein (Luckins, 1977) were injected subcutaneously at day 0 and again intramuscularly at day 7 and day 21. Following this, 5 mg of protein were given subcutaneously at day 22 and intravenously at day 23. The first dose was given with complete Freund's adjuvant (Difco), subsequent injections were given in 140 mm sodium chloride. Antisera were collected 7 days after the last injection and stored at -40 'C. The activity of the hyperimmune serum was analysed against the soluble proteins obtained from TREU 1942 by SDS-PAGE and standard immunoblotting techniques. At least 250 antigens were detected using this antiserum (R. Boid, personal communication). The specific antibody content of the serum was tested by ELISA (Luckins, 1986 ) using the same antigen preparation.
An immunoglobulin fraction of the antiserum was obtained by precipitation using ammonium sulphate, reconstitution in PBS and then extensive dialysis against the same buffer. The protein concentration of the immunoglobulin fraction was determined using BCA protein assay reagent (Pierce Chemical Company) before conjugation with horseradish peroxidase (Rae & Luckins, 1984) .
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Serological tests
For each ofthe enzyme immunoassays, optimal antigen, antibody and conjugate dilutions were established by chequerboard titrations using 'negative' control sera from uninfected camels at Edinburgh Zoo and 'positive' control sera selected from camels with parasitologically proven T. evansi infections. The three test assays were:
(1) a conventional ELISA test for detecting trypanosomal antibodies as described by Luckins (1986) (Test 1); (2) an assay using commercially available staphylococcal Protein A labelled with horseradish peroxidase to detect primarily IgG class trypanosomal antibodies (Zweygarth, Sabwa & Rottcher, 1986 ) (Test 2); (3) a double antibody sandwich ELISA technique for detecting circulating trypanosomal antigens (Luckins, 1986 ) (Test 3). All three enzyme immunoassays were conducted using the substrate 3,3'5,5'-tetramethylbenzidine (Sigma) as described by Luckins (1986) . Plates were set to zero absorbance using the PBS-T control wells.
Data recording
For each camel, data were recorded on: (1) the presence or absence of patent infection, as determined by microscopic examination of blood; (2) the optical density values of the three ELISA tests; (3) the month in which the camel was sampled. Data were initially recorded on the 'PANACEA' database management system (Pan Livestock Services, Department of Agriculture, University of Reading) on an AMSTRAD PC1640 microcomputer, and were then moved to an AMDAHL mainframe computer at the University of Edinburgh's Computer Service, where they were inspected using the 'MINITAB' statistical package (Ryan, Joiner & Ryan, 1985) .
RESULTS
The results of the parasitological investigation showed that of the 944 camels considered, 751 of zero (to two decimal places) is indicated by a dotted line in the left-hand bar of each figure, values of zero being plotted above the dotted line. Fig. 1 a-c depicts the distribution of the results of the three ELISAs from the 193 camels which had patent infection. In Fig. 1 a,b for those camels with ELISA values greater than zero (to two decimal places), the shape of the histograms is suggestive of the Normal. The shape of the histogram in Fig. 1 October 1985) when no patent infections were identified. Fig. 3a ,c, again for camels with ELISA values greater than zero, suggests an exponential distribution. In contrast, Fig. 3b is similar to a Normal distribution. Fig. 4a-c Fig. 4a. Fig. 4b indicates an exponential distribution, whereas Fig.  4c suggests a lognormal one (again, for animals with ELISA values greater than zero). ELISA in camel trypano8omiasis 305 DISCUSSION Diagnosis of trypanosomiasis in individual camels at risk from infection with T. evansi is dependent on a number of factors: those relating to host-parasite interaction including levels of parasitaemia and presence or absence of trypanosomal antibodies, and those relating to the type of diagnostic test used, particularly its detection limits. Hence, in chronic infections parasites may be few in number and difficult to detect. In camels with active infections, examination of blood microscopically fails to identify less than half of those animals shown to be infected by rodent inoculation (Godfrey & Killick-Kendrick, 1962) . Serological assays may provide a convenient alternative to examination of blood films for identification of infection with T. evansi. Previous surveys for trypanosomiasis in camels have shown that in areas where the disease occurs large numbers of camels show serological evidence of infection (Luckins et al. 1979) . However, problems in the interpretation of the results of serological assays such as ELISA tests means that it is difficult to determine the infection status of individual animals.
Experimental evidence indicates the extent of these problems. Thus, in camels and rabbits infected with T. evansi, antibodies appear within 14 days of infection and remain throughout the duration of -the infection. Following treatment and elimination of infection, although there is decline, antibodies persist in the circulation for up to 100 days after treatment (Luckins, Gray & Rae, 1978; Luckins et al. 1979) . Antigens released by the parasites can be detected in serum as early as 5 days after infection. After trypanocidal drug treatment, antigen is no longer detectable 7 days after treatment (Rae & Luckins, 1984 (Fig  1 a-c) is consistent with their current infection. Fig. 3a,c (Fig. 3b) is similar to that depicted in Fig. lb relating to camels with patent infection. Thus, Test 2 is not good at discriminating between camels with and without current infection.
The second period (November 1985 to December 1986) was characterized by both patently and not-patently infected animals and therefore may have included animals with ELISA values resulting from both current and previous infections. Furthermore, camels that are not patently infected may have non-patent infections: Godfrey & Killick-Kendrick (1962) showed that approximately 60% of camels without patent infections are non-patently infected. Fig. 4af -c thus relates to camels which may, or may not, be non-patently infected, in the approximate ratio of 6:4 respectively. Test 1 (Fig. 4a) implies current infection (a Normal distribution) and previous infection with waning antibody levels (an exponential distribution), with the two distributions clearly separated, and could thus be used to identify current infection (patent or non-patent). Fig. 2 a, depicting the results of this test for the full study period, substantiates this inference. Test 2 (Fig. 4b) does not display a Normal component and therefore is unsuitable for detecting current infections. In contrast, Test 3 (Fig. 4c) has a lognormal distribution. This can be transformed to a Normal one and therefore may be suitable for identifying current infections, either patent or non-patent.
This investigation of three ELISAs suggests that the test for circulating antibody (Test 1) is likely to be the best test for differentiating between noninfected and infected (either patently or non-patently) camels. Test 3 is also capable of identifying infection.
Further work is required to determine the best fit of a statistical distribution to the continuous data that result from the tests. It appears from the histograms that this fit will be achieved by consideration of exponential, Normal and lognormal distributions.
